Less commonly, patients experienced infusion site reactions, hyperglycemia, increased insulin requirements, gastrointestinal distress, headaches, hearing loss, tinnitus, dizziness, urinary tract infections (UTIs), weight changes, and altered appetite. Here, INS is linked to urinary tract infection.